Furthermore, the CD38–dara complex formed by CD38 and daratumumab is phagocytosed by monocytes and granulocytes, leading to MM cells displaying altered surface antigen profiles and thus promoting immune evasion. This evidence concerns the gene CD38 and Miyoshi myopathy.